Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
D 9.99 -4.03% -0.42
AUPH closed down 4.03 percent on Friday, June 9, 2023, on 77 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.03%
NR7 Range Contraction -4.03%
NR7-2 Range Contraction -4.03%
Narrow Range Bar Range Contraction -4.03%
Inside Day Range Contraction -4.03%
20 DMA Support Bullish -4.86%
MACD Bullish Signal Line Cross Bullish -4.86%
NR7 Range Contraction -4.86%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 9 hours ago
20 DMA Support about 11 hours ago
60 Minute Opening Range Breakdown about 11 hours ago
Down 2 % about 11 hours ago
Fell Below 20 DMA about 11 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Life Sciences Drugs Clinical Development Autoimmune Disease Peptides Lupus Nephrology Immunosuppressants Lupus Nephritis Nephritis

Is AUPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.6
52 Week Low 4.07
Average Volume 2,675,036
200-Day Moving Average 8.11
50-Day Moving Average 10.64
20-Day Moving Average 10.20
10-Day Moving Average 9.74
Average True Range 0.55
RSI (14) 46.24
ADX 17.91
+DI 22.50
-DI 27.39
Chandelier Exit (Long, 3 ATRs) 9.98
Chandelier Exit (Short, 3 ATRs) 10.50
Upper Bollinger Bands 11.59
Lower Bollinger Band 8.81
Percent B (%b) 0.43
BandWidth 27.25
MACD Line -0.19
MACD Signal Line -0.23
MACD Histogram 0.0451
Fundamentals Value
Market Cap 1.26 Billion
Num Shares 126 Million
EPS -0.70
Price-to-Earnings (P/E) Ratio -14.33
Price-to-Sales 13945.98
Price-to-Book 4.65
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.73
Resistance 3 (R3) 10.81 10.64 10.61
Resistance 2 (R2) 10.64 10.45 10.60 10.57
Resistance 1 (R1) 10.32 10.33 10.23 10.24 10.53
Pivot Point 10.15 10.15 10.10 10.11 10.15
Support 1 (S1) 9.82 9.96 9.74 9.74 9.45
Support 2 (S2) 9.65 9.84 9.61 9.41
Support 3 (S3) 9.33 9.65 9.37
Support 4 (S4) 9.25